Chayma B.
- Country
- France
- Department
- Medical Oncology Department
Research Overview
Data & Insights
Has run more than one trial at 16 of 68 partner sites.
Specializations
Breast Cancer Research
This investigator specializes in advanced therapeutic approaches for hormone receptor-positive breast cancer, with particular focus on HER2-negative breast cancer variants.
- Endocrine-Sensitive Breast Cancer
- PIK3CA-Mutated Cancer Types
- Advanced Stage Disease Management
The research explores combination therapy approaches in advanced breast cancer treatment.
Molecular Oncology
Primary research interests include targeted molecular therapies with specific attention to PIK3CA mutations and their role in cancer progression.
- Molecular Pathway Inhibition
- Hormone Receptor Signaling
- Growth Factor Pathways
The investigator focuses on understanding molecular mechanisms in cancer development.
Therapeutic Innovation
Expertise in developing combination treatment strategies, particularly involving CDK4/6 inhibitors and hormone therapy approaches.
- Novel Drug Combinations
- Endocrine Therapy
- Disease Progression Assessment
The research encompasses innovative therapeutic combinations for advanced cancer treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.